| Moderna | Commercial | $20.4B | Infectious Diseases, Oncology |
| Anto Biosciences | phase-1 | — | Gastroenterology, Immunology |
| Alltrna | Pre-clinical | — | Rare Diseases, Genetic Disorders |
| Ring Therapeutics | platform | — | Genetic Diseases, Oncology |
| Metaphore Biotechnologies | Pre-clinical | — | Metabolic Disease, Obesity |
| Prologue Medicines | Pre-clinical | — | — |
| Apriori Bio | Pre-clinical | — | Infectious Disease |
| Montai Therapeutics | Pre-clinical | — | Gastroenterology, Dermatology |
| Sail Biomedicines | Pre-clinical | — | Autoimmune, Metabolic |
| Etiome | Pre-clinical | — | — |
| Abiologics | Pre-clinical | — | Oncology, Immunology |
| Tessera Therapeutics | Phase 1 | — | Genetic Diseases, Infectious Disease |
| Harbinger Health | Pre-clinical | — | Oncology |
| Expedition Medicines | Pre-clinical | — | Oncology, Immunology |
| Repertoire Immune Medicines | Phase 1 | — | Oncology, Autoimmune Diseases |
| Ampersand Biomedicines | Pre-clinical | — | Oncology, Autoimmune Diseases |
| Senda Biosciences | platform | — | Genetic Diseases, Metabolic Diseases |
| Maven Bio | preclinical | — | Oncology, Immunology |
| Ligo Biosciences | platform | — | Oncology, Immunology |
| Kopra Bio | preclinical | — | Oncology, Immunology |
| Borealis Biosciences | preclinical | — | Metabolic, Gastroenterology |
| Viome | commercial | — | Microbiome, Digestive Health |
| Bolt Threads | commercial | — | — |
| Manakin Bio | preclinical | — | Infectious Diseases |
| ImmunoGenix | preclinical | — | Oncology, Immunology |
| Converge Bio | platform | — | Oncology, Immunology |
| Orbital Therapeutics | preclinical | — | Infectious Disease, Oncology |
| Immunai | platform | — | Oncology, Immunology |
| GeneEdit Therapeutics | preclinical | — | Genetics & Genomics, Rare Diseases |
| KAHR Medical | preclinical | — | Genetic Disorders, Oncology |